The Arg16Glyβ2-adrenergic receptor polymorphism influences long term clinical responses to β2-agonist

Japanese Journal of Allergology

Volumn 57, Issue 6, 2008, Pages 713-721

  Isada, Akira ^a   Hizawa, Nobuyuki ^a   Shimizu, Kenichi ^a   Shimizu, Kaoruko ^a   Takahashi, Ayumu ^a   Hattori, Takeshi ^a   Maeda, Yukiko ^a   Takahashi, Daisuke ^a   Konno, Satoshi ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 adrenergic receptor; 2 agonist; Bronchial asthma; Polymorphism

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; SHORT ACTING DRUG; STEROID; THEOPHYLLINE; ADRBK2 PROTEIN, HUMAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR KINASE 3;

ADD ON THERAPY; ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; JAPANESE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT OUTCOME; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADRENERGIC BETA-AGONISTS; ASTHMA; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 3; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 48349096820     PISSN: 00214884     EISSN: 13477935     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, et al. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A 1987; 84: 46-50.
2. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, et al. Genetic susceptibility to asthma - bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
3. Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RA, Keller P, et al. Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987; 262: 7321-7.
4. Liggett SB. Genetics of beta2-adrenergic receptor variants in asthma. Clin Exp Allergy 1995; 25 Suppl 2: 89-96.
5. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102: 1927-32.
6. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33: 9414-9.
7. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB. Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25-33.
8. Moore PE, Laporte JD, Abraham JH, Schwartzman IN, Yandava CN, Silverman ES, et al. Polymorphism of the beta (2) - adrenergic receptor gene and desensitization in human airway smooth muscle. Am J Respir Crit Care Med 2000; 162: 2117-24.
9. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100: 3184-8.
10. Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, et al. The effect of polymorphisms of the beta (2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162: 75-80.
11. Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364: 1505-12.
12. Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr, Boushey HA, Deykin A, et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006; 173: 519-26.
13. Japanese source
14. Munakata M, Harada Y, Ishida T, Saito J, Nagabukuro A, Matsushita H, et al. Molecular-based haplotype analysis of the beta2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects. Allergol Int 2006; 55: 191-8.
15. Fukui Y, Hizawa N, Takahashi D, Maeda Y, Jinushi E, Konno S, et al. Association between nonspecific airway hyperresponsiveness and Arg16Gly beta2-adrenergic receptor gene polymorphism in asymptomatic healthy Japanese subjects. Chest 2006; 130: 449-54.
16. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitization in moderately severe stable asthmatics. Lancet 1997; 350: 995-9.
17. 2-adrenergic receptor. N Engl J Med 2002; 346: 536-8.
18. 2-adrenoceptor-mediated responses in human lung mast cells. Br J Pharmacol. (In press)
19. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992 20; 326: 501-6.
20. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006 20; 144: 904-12.
21. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995; 346: 201-6.
22. Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391-6.
23. Salpeter SR, Ormiston TM, Salpeter EE. Meta-analysis: respiratory tolerance to regular beta 2-agonist use in patients with asthma. Ann Intern Med 2004 18; 140: 802-13.
24. Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997; 100: 1513-9.
25. Heijink IH, van den, Berge M, Vellenga E, de Monchy JG, Postma DS, Kauffman HF. Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma Clin Exp Allergy 2004; 34: 1356-63.
26. Chong LK, Suvarna K, Chess-Williams R, Peachell PT. Desensitization of beta 2-adrenoceptor-mediated responses by short-acting beta 2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 2003; 138: 512-20.
27. Kamachi A, Munakata M, Nasuhara Y, Nishimura M, Ohtsuka Y, Amishima M, et al. Enhancement of goblet cell hyperplasia and airway hyperresponsiveness by salbutamol in a rat model of atopic asthma. Thorax 2001; 56: 19-24.
28. Lee DK, Currie GP, Hall IP, Lima JJ, Lipworth BJ. The arginine-16 beta 2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004; 57: 68-75.
29. Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI. Asthma exacerbations during long term beta agonist use: influence of beta (2) adrenoceptor polymorphism. Thorax 2000; 55: 762-7.
30. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129: 15-26.